Pictet Asset Management Holding SA cut its stake in Celsius Holdings, Inc. (NASDAQ:CELH - Free Report) by 60.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 21,182 shares of the company's stock after selling 32,799 shares during the quarter. Pictet Asset Management Holding SA's holdings in Celsius were worth $558,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently bought and sold shares of CELH. HM Payson & Co. boosted its stake in shares of Celsius by 122.2% during the fourth quarter. HM Payson & Co. now owns 1,000 shares of the company's stock valued at $26,000 after purchasing an additional 550 shares during the period. S.A. Mason LLC grew its stake in Celsius by 100.0% in the 4th quarter. S.A. Mason LLC now owns 1,400 shares of the company's stock worth $37,000 after acquiring an additional 700 shares in the last quarter. GAMMA Investing LLC raised its stake in shares of Celsius by 185.7% during the fourth quarter. GAMMA Investing LLC now owns 1,714 shares of the company's stock valued at $45,000 after acquiring an additional 1,114 shares in the last quarter. Blue Trust Inc. boosted its holdings in shares of Celsius by 32.8% in the fourth quarter. Blue Trust Inc. now owns 1,786 shares of the company's stock valued at $47,000 after purchasing an additional 441 shares during the period. Finally, Knuff & Co LLC bought a new position in Celsius in the fourth quarter worth approximately $50,000. 60.95% of the stock is owned by hedge funds and other institutional investors.
Celsius Price Performance
NASDAQ:CELH traded up $0.02 during mid-day trading on Monday, hitting $37.31. The company's stock had a trading volume of 529,765 shares, compared to its average volume of 9,944,375. The business's fifty day moving average is $29.42 and its two-hundred day moving average is $29.05. The stock has a market cap of $9.62 billion, a price-to-earnings ratio of 84.61, a PEG ratio of 2.90 and a beta of 1.58. Celsius Holdings, Inc. has a 1 year low of $21.10 and a 1 year high of $98.85.
Celsius (NASDAQ:CELH - Get Free Report) last posted its earnings results on Thursday, February 20th. The company reported $0.14 EPS for the quarter, topping the consensus estimate of $0.11 by $0.03. Celsius had a return on equity of 51.89% and a net margin of 10.70%. The firm had revenue of $332.20 million for the quarter, compared to analyst estimates of $326.07 million. Analysts anticipate that Celsius Holdings, Inc. will post 0.89 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
Several brokerages have weighed in on CELH. Stifel Nicolaus lowered their target price on Celsius from $45.00 to $37.00 and set a "buy" rating for the company in a report on Monday, February 10th. Roth Mkm reissued a "buy" rating and issued a $38.00 price objective on shares of Celsius in a research note on Friday, February 21st. Needham & Company LLC boosted their target price on shares of Celsius from $40.00 to $45.00 and gave the stock a "buy" rating in a report on Wednesday, April 9th. TD Cowen cut shares of Celsius from a "buy" rating to a "hold" rating and lowered their price target for the company from $40.00 to $29.00 in a report on Wednesday, January 22nd. Finally, LADENBURG THALM/SH SH cut their price objective on shares of Celsius from $62.00 to $58.00 and set a "neutral" rating on the stock in a research report on Thursday, March 27th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $45.29.
View Our Latest Stock Analysis on Celsius
Insider Activity at Celsius
In other news, Director Joyce Russell sold 4,000 shares of the business's stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $28.47, for a total transaction of $113,880.00. Following the completion of the sale, the director now owns 19,106 shares of the company's stock, valued at $543,947.82. The trade was a 17.31 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Paul H. Storey sold 10,188 shares of the firm's stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $25.77, for a total transaction of $262,544.76. Following the completion of the transaction, the insider now directly owns 45,297 shares in the company, valued at $1,167,303.69. This represents a 18.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 2.20% of the company's stock.
About Celsius
(
Free Report)
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.
Read More

Before you consider Celsius, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celsius wasn't on the list.
While Celsius currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.